Clinical trial · Observational
Evaluation of Endoscopic Ultrasound Shear Wave Elastography (EUS-SWE) for the Diagnosis of Pancreatic Adenocarcinoma.
NCT04851106CI-TRIAL-00122976EDENcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To assess the diagnostic accuracy of Shear Wave elastography (SWE) for the diagnosis of pancreatic adenocarcinoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreas Cancer | Pancreatic Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Endoscopic ultrasound | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patient with a solid pancreatic lesion of an undetermined nature
- description
- Patient with a solid pancreatic lesion of an undetermined nature
- interventionNames
- Diagnostic Test: Endoscopic ultrasound
Primary outcomes (1)
- measure
- The negative predictive value (NPV) determined from shear wave elastography
- timeFrame
- 12 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient over 18 years of age * Patient with a solid pancreatic mass of indeterminate origin Exclusion Criteria: * Patient with ASA score 4 or 5 * Patient with contraindication to SonoVue injection * Protected patient : major under guardianship, tutorship or other legal protection, deprived of liberty by judicial or administrative decision
References
Publications (0)
Data not yet available
No reference posted for this study.